175 related articles for article (PubMed ID: 22296641)
1. A bile-inducible membrane protein mediates bifidobacterial bile resistance.
Ruiz L; O'Connell-Motherway M; Zomer A; de los Reyes-Gavilán CG; Margolles A; van Sinderen D
Microb Biotechnol; 2012 Jul; 5(4):523-35. PubMed ID: 22296641
[TBL] [Abstract][Full Text] [Related]
2. Discovering novel bile protection systems in Bifidobacterium breve UCC2003 through functional genomics.
Ruiz L; Zomer A; O'Connell-Motherway M; van Sinderen D; Margolles A
Appl Environ Microbiol; 2012 Feb; 78(4):1123-31. PubMed ID: 22156415
[TBL] [Abstract][Full Text] [Related]
3. A two-component regulatory system controls autoregulated serpin expression in Bifidobacterium breve UCC2003.
Alvarez-Martin P; O'Connell Motherway M; Turroni F; Foroni E; Ventura M; van Sinderen D
Appl Environ Microbiol; 2012 Oct; 78(19):7032-41. PubMed ID: 22843530
[TBL] [Abstract][Full Text] [Related]
4. In silico assigned resistance genes confer Bifidobacterium with partial resistance to aminoglycosides but not to β-lactams.
Fouhy F; O'Connell Motherway M; Fitzgerald GF; Ross RP; Stanton C; van Sinderen D; Cotter PD
PLoS One; 2013; 8(12):e82653. PubMed ID: 24324818
[TBL] [Abstract][Full Text] [Related]
5. Bile-inducible efflux transporter from Bifidobacterium longum NCC2705, conferring bile resistance.
Gueimonde M; Garrigues C; van Sinderen D; de los Reyes-Gavilán CG; Margolles A
Appl Environ Microbiol; 2009 May; 75(10):3153-60. PubMed ID: 19304838
[TBL] [Abstract][Full Text] [Related]
6. A GntR-type transcriptional repressor controls sialic acid utilization in Bifidobacterium breve UCC2003.
Egan M; O'Connell Motherway M; van Sinderen D
FEMS Microbiol Lett; 2015 Feb; 362(4):. PubMed ID: 25688064
[TBL] [Abstract][Full Text] [Related]
7. Transposon mutagenesis in Bifidobacterium breve: construction and characterization of a Tn5 transposon mutant library for Bifidobacterium breve UCC2003.
Ruiz L; Motherway MO; Lanigan N; van Sinderen D
PLoS One; 2013; 8(5):e64699. PubMed ID: 23737995
[TBL] [Abstract][Full Text] [Related]
8. Bifidobacterial biofilm formation is a multifactorial adaptive phenomenon in response to bile exposure.
Kelly SM; Lanigan N; O'Neill IJ; Bottacini F; Lugli GA; Viappiani A; Turroni F; Ventura M; van Sinderen D
Sci Rep; 2020 Jul; 10(1):11598. PubMed ID: 32665665
[TBL] [Abstract][Full Text] [Related]
9. Controlled gene expression in bifidobacteria by use of a bile-responsive element.
Ruiz L; Álvarez-Martín P; Mayo B; de los Reyes-Gavilán CG; Gueimonde M; Margolles A
Appl Environ Microbiol; 2012 Jan; 78(2):581-5. PubMed ID: 22081575
[TBL] [Abstract][Full Text] [Related]
10. A conserved two-component signal transduction system controls the response to phosphate starvation in Bifidobacterium breve UCC2003.
Alvarez-Martin P; Fernández M; O'Connell-Motherway M; O'Connell KJ; Sauvageot N; Fitzgerald GF; MacSharry J; Zomer A; van Sinderen D
Appl Environ Microbiol; 2012 Aug; 78(15):5258-69. PubMed ID: 22635988
[TBL] [Abstract][Full Text] [Related]
11. Cellodextrin utilization by bifidobacterium breve UCC2003.
Pokusaeva K; O'Connell-Motherway M; Zomer A; Macsharry J; Fitzgerald GF; van Sinderen D
Appl Environ Microbiol; 2011 Mar; 77(5):1681-90. PubMed ID: 21216899
[TBL] [Abstract][Full Text] [Related]
12. Identification of iron-regulated genes of Bifidobacterium breve UCC2003 as a basis for controlled gene expression.
Cronin M; Zomer A; Fitzgerald GF; van Sinderen D
Bioeng Bugs; 2012; 3(3):157-67. PubMed ID: 22179149
[TBL] [Abstract][Full Text] [Related]
13. Ribose utilization by the human commensal Bifidobacterium breve UCC2003.
Pokusaeva K; Neves AR; Zomer A; O'Connell-Motherway M; MacSharry J; Curley P; Fitzgerald GF; van Sinderen D
Microb Biotechnol; 2010 May; 3(3):311-23. PubMed ID: 21255330
[TBL] [Abstract][Full Text] [Related]
14. An interactive regulatory network controls stress response in Bifidobacterium breve UCC2003.
Zomer A; Fernandez M; Kearney B; Fitzgerald GF; Ventura M; van Sinderen D
J Bacteriol; 2009 Nov; 191(22):7039-49. PubMed ID: 19734308
[TBL] [Abstract][Full Text] [Related]
15. Bifidobacterium breve UCC2003 Employs Multiple Transcriptional Regulators To Control Metabolism of Particular Human Milk Oligosaccharides.
James K; O'Connell Motherway M; Penno C; O'Brien RL; van Sinderen D
Appl Environ Microbiol; 2018 May; 84(9):. PubMed ID: 29500268
[TBL] [Abstract][Full Text] [Related]
16. Global transcriptional landscape and promoter mapping of the gut commensal Bifidobacterium breve UCC2003.
Bottacini F; Zomer A; Milani C; Ferrario C; Lugli GA; Egan M; Ventura M; van Sinderen D
BMC Genomics; 2017 Dec; 18(1):991. PubMed ID: 29281966
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional and functional characterization of genetic elements involved in galacto-oligosaccharide utilization by Bifidobacterium breve UCC2003.
O'Connell Motherway M; Kinsella M; Fitzgerald GF; van Sinderen D
Microb Biotechnol; 2013 Jan; 6(1):67-79. PubMed ID: 23199239
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of sialic acid by Bifidobacterium breve UCC2003.
Egan M; O'Connell Motherway M; Ventura M; van Sinderen D
Appl Environ Microbiol; 2014 Jul; 80(14):4414-26. PubMed ID: 24814790
[TBL] [Abstract][Full Text] [Related]
19. Two membrane proteins from Bifidobacterium breve UCC2003 constitute an ABC-type multidrug transporter.
Margolles A; Flórez AB; Moreno JA; van Sinderen D; de Los Reyes-Gavilán CG
Microbiology (Reading); 2006 Dec; 152(Pt 12):3497-3505. PubMed ID: 17159201
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of a plant derived galactose-containing polysaccharide by Bifidobacterium breve UCC2003.
O'Connell Motherway M; Fitzgerald GF; van Sinderen D
Microb Biotechnol; 2011 May; 4(3):403-16. PubMed ID: 21375716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
